Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLeukemiaTeam Member asked a question 💭
September 17, 2025
 · 
Reactions
MyLeukemiaTeam

The generic form of nilotinib (Danziten) has one key difference from Tasigna - it can be taken with or without food. This is a significant improvement since Tasigna must be taken on an empty stomach with strict fasting requirements before and after taking the medication.

This new formulation was specifically designed to Show Full Answer

The generic form of nilotinib (Danziten) has one key difference from Tasigna - it can be taken with or without food. This is a significant improvement since Tasigna must be taken on an empty stomach with strict fasting requirements before and after taking the medication.

This new formulation was specifically designed to help people stick better to their treatment plan by removing the mealtime restrictions. Both medications are equally effective for treating Philadelphia chromosome-positive CML, whether you're newly diagnosed or resistant to other treatments. The main difference is really just the flexibility around when you can take it in relation to meals.

September 17, 2025

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
San Jose, CA

A MyLeukemiaTeam Member asked a question 💭
Oceanside, CA

A MyLeukemiaTeam Member asked a question 💭
Maumee, OH